Clinical Study on the Mass Balance of Clifutinib

Clinical trial NCT07211165 · COMPLETED

Trial details

NCT number: NCT07211165
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Male

Start date: 2025-09-29
Primary completion: 2025-11-05
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.